Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations

PW InghamAP McMahonHedgehog signaling in animal development: paradigms and principlesGenes Dev1530593087200110.1101/gad.93860111731473

M Pasca di MaglianoM HebrokHedgehog signaling in cancer formation and maintenanceNat Rev Cancer3903911200314737121

H ZhuH-W LoThe human glioma-associated oncogene homolog 1 (GLI1) family of transcription factors in gene regulation and diseasesCurr Genomics11238245201010.2174/13892021079123310821119888

WJ IngramCA WickingSM GrimmondAR ForrestBJ WainwrightNovel genes regulated by sonic hedgehog in pluripotent mesenchymal cellsOncogene2181968205200210.1038/sj.onc.120597512444557

M Duman-ScheelL WengS XinW DuHedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin ENature417299304200210.1038/417299a12015606

DN WatkinsDM BermanSG BurkholderB WangPA BeachySB BaylinHedgehog signaling within airway epithelial progenitors and in small-cell lung cancerNature422313317200310.1038/nature0149312629553

M KuboM NakamuraA TasakiHedgehog signaling pathway is a new therapeutic target for patients with breast cancerCancer Res6460716074200410.1158/0008-5472.CAN-04-041615342389

SP ThayerMP di MaglianoPW HeiserHedgehog is an early and late mediator of pancreatic cancer tumorigenesisNature425851856200310.1038/nature0200914520413

CM RudinCL HannJ LaterraTreatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449N Engl J Med36111731178200910.1056/NEJMoa090290319726761

I CaroJA LowThe role of the hedgehog signaling pathway in the development of basal cell carcinoma and opportunities for treatmentClin Cancer Res1633353339201010.1158/1078-0432.CCR-09-257020439455

DD Von HoffPM LoRussoCM RudinInhibition of the hedgehog pathway in advanced basal-cell carcinomaN Engl J Med36111641172200919726763

JA LowFJ de SauvageClinical experience with hedgehog pathway inhibitorsJ Clin Oncol2853215326201010.1200/JCO.2010.27.994321041712

JY YangAA MarghoobEmerging treatments and signaling pathway inhibitorsSemin Cutan Med Surg31S14S182011

JK ChenJ TaipaleMK CooperPA BeachyInhibition of hedgehog signaling by direct binding of cyclopamine to smoothenedGenes Dev1627432748200210.1101/gad.102530212414725

Z YuanJA GoetzS SinghFrequent requirement of hedgehog signaling in non-small cell lung carcinomaOncogene2610461055200710.1038/sj.onc.120986016909105

Y MaS FieringC BlackTransgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomasProc Natl Acad Sci USA10440894094200710.1073/pnas.060653710417360482

GJP DijkgraafB AlickeL WeinmannSmall molecule inhibition of GDC-0449 refractory smoothened mutants and downstream mechanisms of drug resistanceCancer Res71435444201110.1158/0008-5472.CAN-10-287621123452

RL YauchGJP DijkgraafB AlickeSmoothened mutation confers resistance to a hedgehog pathway inhibitor in medulloblastomaScience326572574200910.1126/science.117938619726788

F GalimbertiSL ThompsonX LiuTargeting the cyclin E-cdk-2 complex represses lung cancer growth by triggering anaphase catastropheClin Cancer Res16109120201010.1158/1078-0432.CCR-09-215120028770

X LiuLF SempereH OuyangMicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressorsJ Clin Invest12012981309201010.1172/JCI3956620237410

X LiuLF SempereF GalimbertiUncovering growth-suppressive microRNAs in lung cancerClin Cancer Res1511771183200910.1158/1078-0432.CCR-08-135519228723

S GuptaN TakebeP LorussoTargeting the hedgehog pathway in cancerTher Adv Med Oncol2237250201010.1177/1758834010366430

U McDermottSV SharmaL DowellIdentification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profilingProc Natl Acad Sci USA1041993619941200710.1073/pnas.070749810418077425

U McDermottSV SharmaJ SettlemanHigh-throughput lung cancer cell line screening for genotype-correlated sensitivity to an EGFR kinase inhibitorMethods Enzymol438331341200810.1016/S0076-6879(07)38023-318413259

R: Test for Association/Correlation Between Paired Sampleshttp://stat.ethz.ch/R-manual/R-patched/library/stats/html/cor.test.html

rproject.orghttp://www.rproject.org/

GSK Cancer Cell Line Genomic Profiling Datahttps://cabig.nci.nih.gov/caArray_GSKdata/

S BamfordE DawsonS ForbesThe COSMIC (catalogue of somatic mutations in cancer) database and websiteBr J Cancer91355358200415188009

E LindströmT ShimokawaR ToftgårdPG ZaphiropoulosPTCH mutations: distribution and analysesHum Mutat27215219200616419085

SJ FreemantleE DmitrovskyCyclin E transgenic mice: discovery tools for lung cancer biology, therapy, and preventionCancer Prev Res315131518201010.1158/1940-6207.CAPR-10-029721149327

Q FengD SekulaY GuoUBE1L causes lung cancer growth suppression by targeting cyclin D1Mol Cancer Ther737803788200810.1158/1535-7163.MCT-08-075319074853

E MassarelliM Varella-GarciaX TangKRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancerClin Cancer Res1328902896200710.1158/1078-0432.CCR-06-304317504988

KH DragnevT MaJ CyrusBexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic modelsCancer Prev Res4818828201110.1158/1940-6207.CAPR-10-037621636548

H LinardouIJ DahabrehD KanaloupitiAssessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancerLancet Oncol9962972200810.1016/S1470-2045(08)70206-718804418

W PaoTY WangGJ RielyKRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinibPLoS Med2e17e17200510.1371/journal.pmed.002001715696205

S SinghZ WangD Liang FeiHedgehog-producing cancer cells respond to and require autocrine hedgehog activityCancer Res7144544463201110.1158/0008-5472.CAN-10-231321565978

J VestergaardMW PedersenN PedersenHedgehog signaling in small-cell lung cancer: frequent in vivo but a rare event in vitroLung Cancer52281290200610.1016/j.lungcan.2005.12.01416616798

JK ChenJ TaipaleKE YoungT MaitiPA BeachySmall molecule modulation of smoothened activityProc Natl Acad Sci USA991407114076200210.1073/pnas.18254289912391318

F GalimbertiSL ThompsonS RaviDA ComptonE DmitrovskyAnaphase catastrophe is a target for cancer therapyClin Cancer Res1712181222201110.1158/1078-0432.CCR-10-117821288923

J Sims-MourtadaJG IzzoJ AjaniKSC ChaoSonic hedgehog promotes multiple drug resistance by regulation of drug transportOncogene2656745679200710.1038/sj.onc.121035617353904

T TangJY TangD LiTargeting superficial or nodular basal cell carcinoma with topically formulated small molecule inhibitor of smoothenedClin Cancer Res1733783387201110.1158/1078-0432.CCR-10-337021558397